Physician profile
Linda I Suleiman
NPI 1396008116
$897,883.87
in general payments reported to CMS, 2019-2025
16 companies · $657K in 2025
The $657K reported for 2025 was more than what 97% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,561 · 2020: $9,774 · 2021: $17K · 2022: $31K · 2023: $40K · 2024: $142K · 2025: $657K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $577K · Royalty Or License: $120K · Education: $107K · Travel and Lodging: $24K · Food and Beverage: $10K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $576,850.00 |
| Royalty Or License | $120,472.35 |
| Education | $106,800.00 |
| Travel and Lodging | $23,640.84 |
| Food and Beverage | $10,083.83 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $661,974.44 | 2023-2025 | G7, Arcos, Avenir |
| Omnilife Science, INC | $124,087.66 | 2022-2024 | Corin Technology, Omnibotics 3.0, Various Products |
| Stryker Corporation | $46,206.49 | 2019-2025 | Insignia, Mako, Accolade |
| Medical Device Business Services, INC. | $20,616.06 | 2021-2023 | Dermabond, Stratafix, Emphasys |
| Total Joint Orthopedics, INC. | $11,351.14 | 2021-2024 | |
| Ethicon Endo-Surgery INC. | $10,560.00 | 2021-2023 | Monocryl, Dermabond Prineo, Stratafix |
| Depuy Synthes Sales INC. | $7,706.47 | 2021-2023 | Velys, Attune |
| Ethicon INC. | $6,358.03 | 2023-2024 | Stratafix, Dermabond, Vicryl |
| Microport Orthopedics INC | $3,709.91 | 2020 | |
| Ethicon US, LLC | $2,314.82 | 2021-2023 | Stratafix |
| Synthes Gmbh | $2,123.82 | 2023 | |
| Linkbio Corp | $410.72 | 2023-2025 | |
| Medacta USA, INC. | $198.45 | 2019-2021 | |
| Smith+Nephew, INC. | $104.22 | 2019 | |
| Think Surgical, INC. | $99.19 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $62.45 | 2025 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$625,391.25 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Suleiman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.